Scottie Resources Corp.: Scottie Resources Reports 27.9 g/t Gold over 4.15 m and 51.6 g/t Gold over 2.25 m at Blueberry Contact Zone

Chevron and Egypt's Ministry of Petroleum announced positive results from the Nargis-2 gas well in the Mediterranean. The well confirmed extended gas-bearing reservoirs and an additional gas interval, supporting further appraisal and development. Chevron operates the area with partners Eni, Mubadala Energy, and Tharwa Petroleum. The well reached 5,000 meters with 35 meters of net gas pay, indicating potential for further development.

Genmab and Incyte are collaborating on clinical trials for metastatic colorectal cancer. The trials will evaluate the combination of Genmab's petosemtamab and Incyte's INCB161734 with standard chemotherapy. Petosemtamab targets EGFR and LGR5, while INCB161734 inhibits KRAS G12D. The companies aim to provide a new treatment option for patients with KRAS G12D-mutated metastatic colorectal cancer.

Incyte (INCY) and Genmab (GMAB) are collaborating on a clinical trial to evaluate Incyte's KRAS G12D inhibitor INCB161734 with Genmab's bispecific antibody petosemtamab and standard chemotherapy for metastatic colorectal cancer with KRAS G12D mutation. The Phase 1/2 study will be co-funded by both companies, with Genmab conducting the trial and Incyte providing the clinical supply of INCB161734. This collaboration aims to address a significant unmet medical need in this patient population.

Incyte (INCY) and Genmab will collaborate on a Phase 1/2 trial for KRAS G12D-mutated metastatic colorectal cancer, combining Incyte's INCB161734 with Genmab's petosemtamab and chemotherapy. Incyte will co-fund and supply the drug, while Genmab will lead the study.

GM invested $108M in sodium-ion battery startup Peak Energy and plans to introduce eyes-off driving in its large SUVs and pickups. The automaker aims to compete with Tesla and Chinese manufacturers through software updates and higher-margin services. GM expects digital revenue to grow from $3.2B to $9.6B by 2036, according to UBS.

Allegiant Travel Company exercised options for six more Boeing 737 MAX 8 aircraft, scheduled for 2028 delivery, increasing its firm commitment to 56 aircraft. The jets have a combined list price of over $720 million, with an estimated market value of $351 million. Allegiant is transitioning from Airbus to Boeing, citing lower fuel consumption and improved reliability. The company also acquired Sun Country Airlines in 2026.